- Home
- SCLX vs NXB Comparison
SCLX vs NXB Comparison
Compare SCLX & NXB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCLX | NXB |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | |
| Employees | 34 | 40 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.1M | 49.2M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | SCLX | NXB |
|---|---|---|
| Price | $6.79 | $1.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 119.0K | 46.5K |
| Earning Date | 04-10-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $122.52 | N/A |
| Revenue Next Year | $186.30 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.20 | $1.81 |
| 52 Week High | $34.27 | $2.57 |
Technical Indicators
Market Signals| Indicator | SCLX | NXB |
|---|---|---|
| Relative Strength Index (RSI) | 39.46 | 45.85 |
| Support Level | $5.72 | N/A |
| Resistance Level | $7.77 | $2.40 |
| Average True Range (ATR) | 0.79 | 0.13 |
| MACD | -0.26 | -0.02 |
| Stochastic Oscillator | 0.27 | 30.85 |
Price Performance
Historical ComparisonAbout SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
About NXB NextBoat Inc. Common Stcok
NextBoat Inc focused on AI-powered technology platform designed to modernize and scale the world-wide pre-owned marine marketplace.